Sign In
Buy TRMK
Trustmark Earnings Calls
| Release date | Apr 28, 2026 |
| EPS estimate | $0.87 |
| EPS actual | $0.95 |
| EPS Surprise | 9.20% |
| Revenue estimate | 204.98M |
| Revenue actual | 208.072M |
| Revenue Surprise | 1.51% |
| Release date | Jan 27, 2026 |
| EPS estimate | $0.91 |
| EPS actual | $0.97 |
| EPS Surprise | 6.59% |
| Revenue estimate | 206.64M |
| Revenue actual | 209.441M |
| Revenue Surprise | 1.36% |
| Release date | Oct 28, 2025 |
| EPS estimate | $0.93 |
| EPS actual | $0.94 |
| EPS Surprise | 0.86% |
| Revenue estimate | 205.86M |
| Revenue actual | 243.158M |
| Revenue Surprise | 18.12% |
| Release date | Jul 22, 2025 |
| EPS estimate | $0.87 |
| EPS actual | $0.92 |
| EPS Surprise | 5.87% |
| Revenue estimate | 206.125M |
| Revenue actual | 249.08M |
| Revenue Surprise | 20.84% |
Last 4 Quarters for Trustmark
Below you can see how TRMK performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 22, 2025 |
| Price on release | $38.72 |
| EPS estimate | $0.87 |
| EPS actual | $0.92 |
| EPS surprise | 5.87% |
| Date | Price |
|---|---|
| Jul 16, 2025 | $38.00 |
| Jul 17, 2025 | $38.30 |
| Jul 18, 2025 | $38.55 |
| Jul 21, 2025 | $38.52 |
| Jul 22, 2025 | $38.72 |
| Jul 23, 2025 | $38.34 |
| Jul 24, 2025 | $38.59 |
| Jul 25, 2025 | $38.67 |
| Jul 28, 2025 | $38.25 |
| 4 days before | 1.89% |
| 4 days after | -1.21% |
| On release day | -0.98% |
| Change in period | 0.658% |
| Release date | Oct 28, 2025 |
| Price on release | $38.70 |
| EPS estimate | $0.93 |
| EPS actual | $0.94 |
| EPS surprise | 0.86% |
| Date | Price |
|---|---|
| Oct 22, 2025 | $37.97 |
| Oct 23, 2025 | $38.04 |
| Oct 24, 2025 | $38.74 |
| Oct 27, 2025 | $38.73 |
| Oct 28, 2025 | $38.70 |
| Oct 29, 2025 | $37.95 |
| Oct 30, 2025 | $37.24 |
| Oct 31, 2025 | $37.22 |
| Nov 03, 2025 | $37.39 |
| 4 days before | 1.92% |
| 4 days after | -3.39% |
| On release day | -1.94% |
| Change in period | -1.53% |
| Release date | Jan 27, 2026 |
| Price on release | $41.14 |
| EPS estimate | $0.91 |
| EPS actual | $0.97 |
| EPS surprise | 6.59% |
| Date | Price |
|---|---|
| Jan 21, 2026 | $42.64 |
| Jan 22, 2026 | $42.54 |
| Jan 23, 2026 | $40.82 |
| Jan 26, 2026 | $40.91 |
| Jan 27, 2026 | $41.14 |
| Jan 28, 2026 | $42.11 |
| Jan 29, 2026 | $42.32 |
| Jan 30, 2026 | $42.52 |
| Feb 02, 2026 | $43.01 |
| 4 days before | -3.52% |
| 4 days after | 4.55% |
| On release day | 2.36% |
| Change in period | 0.87% |
| Release date | Apr 28, 2026 |
| Price on release | $45.50 |
| EPS estimate | $0.87 |
| EPS actual | $0.95 |
| EPS surprise | 9.20% |
| Date | Price |
|---|---|
| Apr 22, 2026 | $44.52 |
| Apr 23, 2026 | $44.91 |
| Apr 24, 2026 | $44.44 |
| Apr 27, 2026 | $45.08 |
| Apr 28, 2026 | $45.50 |
| Apr 29, 2026 | $44.28 |
| Apr 30, 2026 | $44.37 |
| May 01, 2026 | $44.91 |
| May 04, 2026 | $44.34 |
| 4 days before | 2.20% |
| 4 days after | -2.55% |
| On release day | -2.68% |
| Change in period | -0.404% |
Trustmark Earnings Call Transcript Summary of Q1 2026
Trustmark reported solid first quarter 2026 results, with net income of $56.1 million and diluted EPS of $0.95. Key fundamentals: loans held for investment rose $203.7 million sequentially (4.8% YoY growth), deposits increased $212.7 million sequentially (4.2% YoY), NIM was stable at 3.81%, and noninterest income grew modestly while noninterest expense was flat sequentially. Credit remained strong: net charge-offs were low at $1.3 million and the ACL was 1.16% of loans. Capital remains healthy (CET1 11.7%), the Board declared a $0.25 quarterly dividend, and the company repurchased $19.8 million of stock in Q1 with authorization to repurchase up to $100 million in 2026. Management affirmed full-year 2026 guidance: single-digit loan growth, mid-single-digit deposit growth (ex-brokered), NIM 3.80%–3.85%, and mid-single-digit increases in NII, noninterest income, and noninterest expense. Priorities remain disciplined capital deployment (organic loan growth, opportunistic M&A, and buybacks), continued investment in revenue producers/technology, and focus on expense management. Risks/uncertainties highlighted include mortgage hedge ineffectiveness volatility and competitive pressure on loan spreads and deposit pricing.
